Friday, July 6, 2018

(Reuters) - A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack.


from Reuters: Health News https://ift.tt/2z9MQLE

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - Parents with depression may be more likely to take their children to the doctor than those without mental health problems, a UK study suggests. from Reuters: Health News https://ift.tt/2O36NXb … Read More
  • LATEST HEALTH NEWSFour people have tested positive for Ebola in eastern Democratic Republic of Congo just days after another outbreak that killed 33 people in the northwest was declared over, the health ministry said on Wednesday. from Re… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Use of prescription opioids remains high in the U.S., despite public health efforts and growing awareness of risks for abuse and overdose, a new study suggests. from Reuters: Health News https://ift.tt… Read More
  • LATEST HEALTH NEWSHONG KONG (Reuters/IFR) - Chinese Nasdaq-listed biotech BeiGene Ltd has raised $903 million after pricing its secondary listing in Hong Kong - the first under new exchange rules - near the top of an indicative range, three pe… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Roughly two in three U.S. teens believe that tougher gun control laws might help prevent mass shootings, a survey suggests. from Reuters: Health News https://ift.tt/2LUme6p … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner